Candidozyma auris (formerly Candida auris): resistant, long lasting, and everywhere
The continued global expansion of C. auris has major clinical, economic, and public health implications. Effective control requires sustained investment in laboratory capacity, standardized nomenclature adoption, active surveillance, genomic monitoring, and rigorous IPC measures tailored to the pathogen's unique biology. Without coordinated regional and international responses, C. auris is likely to continue shifting from epidemic emergence to entrenched endemicity in diverse healthcare systems worldwide.
Authors
- Arnaldo Lopes Colombo (ORCID: https://orcid.org/0000-0003-0793-8491)
- Jon Salmanton-García
- João Nóbrega de Almeida
Institutions
- Hospital Israelita Albert Einstein (BR)
- Düsseldorf University Hospital (DE)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Cologne (DE)
- Hospital São Paulo (BR)
- Heinrich Heine University Düsseldorf (DE)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Clinical Microbiology and Infection
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1016/j.cmi.2025.12.022
- Citations
- 3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 98.35